Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery: A Randomized, Double-blind Trial

NCT06062550 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06062550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery: A Randomized, Double-blind Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 24, 2023
Completion date
October 31, 2026
Enrollment
312 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic postsurgical pain, dexmedetomidine, esketamine, postoperative analgesia, scoliosis correction